<h6>Objective :</h6>
<p>COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.</p>
<h6>Problem Statement:</h6>
<p>A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.</p>
<h6>Our Methodology:</h6>
<ul>
<li>Therapeutic R&amp;D Developmental Pipeline Assessment</li>
<li>Assessment of the Drugs</li>
<li>Key Pharmaceuticals Portfolio Assessment</li>
<li>Strategic Planning Assistance</li>
</ul>
<h6>Results:</h6>
<ul>
<li>Detailed profiling of Active Products in the Pipeline</li>
<li>Landscape analysis of various Mechanisms of Action and Routes of Administration</li>
<li>Matrix Analysis positioned the top 10 Companies researched.</li>
<li>The client can appraise all the top companies that can serve as a potential competition</li>
</ul>

A mid-sized EU-based firm roped in DelveInsight for evaluation of the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They intended to recognize and analyze the emerging therapies, key competitors and study the landscape based on the mechanism of action...

Competitive Landscape of COVID-19 Therapies

Competitive Landscape of COVID-19 therapies provides insights into the key competitors, emerging therapies R&D activities, MoA, and drugs assessment